Tacoma, WA · Founded 2000 · Privately Held (backing)
Developer of an anti-inflammatory therapeutic drug designed to treat a variety of neurological diseases. Revalesio is based in Tacoma, WA and was founded in 2000. Its last reported valuation was $86.4 million in Jul 2020. It has raised $113 million across 6 recorded rounds; the latest was a $38.9 million early-stage round in May 2022.
Last reported valuation
$86.4M
Oct 2026
Priced at
—
Total raised
$112.8M
Last round
Early Stage VC
May 2022
No prints on record
No secondary trades in Revalesio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Revalesio with a free account
·Watch Revalesio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Revalesio stock.
